Recently, STAT4-mediated TKI-resistant pathways were found to compensate for the functional loss of STAT5 (TKI-sensitive) and activate PIM2 to restore the phosphorylation of BAD to support CML relapse (36). Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.